Oncology Letters

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

Oncology Letters

ONCOL LETT

ISSN / eISSN

1792-1074 / 1792-1082

Aims and Scope

Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology, as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease.

The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology, chemotherapy, oncogenes, carcinogenesis, metastasis, epidemiology and viral oncology in the form of original research, reviews and case reports.

Subject Area

ONCOLOGY

CiteScore

6.30

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Oncology	Q2	#119/366
Medicine - Cancer Research	Q2	#99/214

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
ONCOLOGY - SCIE	Q3

H-index

Country/Area of Publication

GREECE

Publisher

Spandidos Publications

Year Publication Started

2010

Annual Article Volume

453

Open Access

Contact

POB 18179, ATHENS, GREECE, 116 10

Popular journals in the same field
Recent articles

Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2: (2023) Xiangtian Shi, Jiarui Yang, Meng Wang, Long Xia, Lei Zhang, Shan Qiao

Efficacy of neoadjuvant therapy for lung squamous cell carcinoma and lung adenocarcinoma: A retrospective comparative study: (2023) Yi Gan, Zhihao Liu, Zhiwei Tang, Xiaojing Yao, Bo Zeng, Haoshuai Zhu

[Retracted] Upregulation of CENPF is linked to aggressive features of osteosarcoma: (2023) Ping-An Zou, Zheng-Xu Yang, Xi Wang, Zhi-Wei Tao

Lack of association between XRCC1 SNPs and acute radiation‑induced injury or prognosis in patients with nasopharyngeal carcinoma: (2023) Yuhong Zheng, Jingfeng Zong, Yansong Chen, Junying Guo, Tianzhu Lu, Xiaoqin Xin, Yan Chen

Metabolic coupling in phyllodes tumor of the breast and its association with tumor progression: (2023) Nah Kim, Min Park, Sun-Seog Kweon, Ji Lee

GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization: (2023) Site Yu, Wenjie Feng, Jizhang Zeng, Situo Zhou, Yinghua Peng, Pihong Zhang

Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX: (2023) Jiang Chang, Chengyi Xin, Yong Wang, Ying Wang

Clinical implications of PNA‑sequencing as a complementary test for EGFR mutation analysis in human lung cancer: (2023) Yi-Lin Chen, Chien-Chung Lin, Yu-Ting Yu, Wan-Li Chen, Shu-Ching Yang, Wenya Huang, Wu-Chou Su, Nan-Haw Chow, Chung-Liang Ho

Influence of tumor mycobiome on cancer pathogenesis (Review): (2023) Weipeng Liu, Zongrui Li, Xiaopeng Li, Haiyang Cao, He Jiang, Qingbin Niu, Baoguang Hu

Mechanistic insights into UHRF1‑mediated DNA methylation by structure‑based functional clarification of UHRF1 domains (Review): (2023) Yiying Song, Haiting Liu, Qingqing Xian, Chengzhi Gui, Mingjie Xu, Yunying Zhou

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

First time submitting a foreign language manuscript, with one minor revision and one major revision, totaling three rounds of revisions. Finally, it is required to upload the sequencing data to the public database for acceptance. However, the sequencing company provided data that does not meet the requirements, and the original data cannot be obtained as it has expired. Unfortunately, the manuscript has to be withdrawn. It's my own fault for not carefully reading the journal's requirement of uploading sequencing data to the public database from the beginning. Sigh... Let this be a lesson for everyone.

2022-06-17

First, the review speed is not slow. Secondly, the editor is very responsible, making multiple small revisions back and forth three times, and each time the editor's response is very prompt.

2023-07-07

View All Reviews

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started